Patent Assignment
Reel/Frame 051634/0928
Assignment of Assignor's Interest
Recorded: 2020-01-27
Pages: 5
Assignor
R.P. SCHERER TECHNOLOGIES, LLC
Executed: 2019-12-04
Assignee
CATALENT U.K. SWINDON ZYDIS LIMITED
FRANKLAND ROAD, BLAGROVE, SWINDON, WILTSHIRE, SN5 8YG, UNITED KINGDOM
Covered Properties
(4)
Process to Minimize Polymorphism
Application:
12/393,584 →
Publication:
US 2009/0226522
Oral Solid Dosage Form Containing Nanoparticles and Process of Formulating the Same Using Fish Gelatin
Process of Manufacturing a Lyophilized Fast Dissolving, Multi-Phasic Dosage Form
Oral Vaccine Fast-Dissolving Dosage Form Using Starch
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Corrective Assignment to Correct the Assignee Address Previously Recorded at Reel: 027291 Frame: 0081. Assignor(S) Hereby Confirms the Assignment .
Mar 12, 2018
From: TIAN, WEI; MCLAUGHLIN, ROSIE
To: R.P. SCHERER TECHNOLOGIES, LLC
Reel/Frame 045558/0610 →
Supplemental Security Agreement
May 20, 2019
From: R.P. SCHERER TECHNOLOGIES, LLC; CATALENT PHARMA SOLUTIONS, LLC; REDWOOD BIOSCIENCE, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 049221/0673 →
Change of Name
Aug 29, 2019
From: R.P. SCHERER TECHNOLOGIES, INC.
To: R.P. SCHERER TECHNOLOGIES, LLC
Reel/Frame 050897/0614 →
Security Interest
Dec 19, 2024
From: CATALENT CTS (KANSAS CITY), LLC; REDWOOD BIOSCIENCE, INC.; R.P. SCHERER TECHNOLOGIES, LLC; CATALENT WELLNESS, LLC
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 069743/0458 →
Release of Security Interest in Patent Collateral (049221/0673)
Dec 19, 2024
From: JPMORGAN CHASE BANK, N.A.
To: CATALENT PHARMA SOLUTIONS, LLC; R.P. SCHERER TECHNOLOGIES, INC.; R.P. SCHERER TECHNOLOGIES, LLC; REDWOOD BIOSCIENCE, INC.
Reel/Frame 069751/0100 →